Diagnosis of acute generalized pustular bacterid facilitated by point‐of‐care testing
The Journal of Dermatology · 2023
DOI: 10.1111/1346-8138.16857 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Ryo Fukaura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Psoriasis, Exanthema, Skin Diseases, Vesiculobullous. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Dear Editor, Acute generalized pustular bacterid (AGPB) is a rare skin manifestation of an infection with GroupA Streptococcus (GAS). Patients present febrile with a widespread pustular eruption. Although a set of diagnostic criteria was proposed in the 1970s,1 some of the criteria, especially of diagnostic technology including bacterial cultures and antistreptolysin O (ASO) measurements, are outdated. Despite QuickNaviTMStrep A (DENKA SEIKEN Co., Ltd.) being a kit that has been used for about 10 years, we have proven for the first time, as far as we know, that AGPB can be diagnosed precisely and quickly by pointofcare testing (POCT) using QuickNaviTMStrep A. A man in his 70s presented with multiple erythematous papules of 6 days and a sore throat. Associated symptoms included pyrexia (37.5– 38.0°) and arthralgia. The skin symptoms were originally described as nonspecific erythema; however, it subsequently became pustular. The pustules were initially concentrated on the forearms but spread to the chest and thighs (Figure 1af). He had recently taken overthecounter bromhexine for coryzal symptoms. The patient was admitted and treated with intravenous ampicillinsulbactam 3 g twice daily, and oral prednisolone 25 mg once daily. Investigations revealed a white blood cell count of 11.2 × 103/ μL (neutrophils > 70%, lymphocytes 12.2%) and a Creactive protein of 6.32 mg/dL. Influenza swabs and blood and urine cultures were negative, but POCT using QuickNaviTMStrep A for GAS was positive. Genetic testing for IL36RN and CARD14 revealed no pathogenic variants. Serum antibodies against BP180, and desmogleins 1 and 3 were negative. Serial ASO measurements were negative at presentation at 3 weeks, and 2 months. A drug induced lymphocytes stimulation test (DLST) with bromhexine returned weakly positive (SI 2.93). A skin biopsy from the left arm revealed subcorneal pustules with neutrophilic infiltration and leukocytoclastic vasculitis
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Ryo Fukaura, Takuya Takeichi, Masashi Akiyama
Zitieren
APA
Fukaura, R., Terashima-Murase, C., Tanahashi, K., Takeichi, T., & Akiyama, M. (2023). Diagnosis of acute generalized pustular bacterid facilitated by point‐of‐care testing. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16857
Vancouver
Fukaura R, Terashima-Murase C, Tanahashi K, Takeichi T, Akiyama M. Diagnosis of acute generalized pustular bacterid facilitated by point‐of‐care testing. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16857
BibTeX
@article{Fukaura2023,
author = {Fukaura, Ryo and Terashima-Murase, Chiaki and Tanahashi, Kana and Takeichi, Takuya and Akiyama, Masashi},
title = {Diagnosis of acute generalized pustular bacterid facilitated by point‐of‐care testing},
journal = {The Journal of Dermatology},
year = {2023},
doi = {10.1111/1346-8138.16857}
}
EUVIMED